Press Room
The CEO of Duchesnay Pharmaceutical Groupe, Éric Gervais, shared his thoughts on the future of the life sciences industry with Investment Reports.
Duchesnay Pharmaceutical Group opened its doors to a Ukrainian refugee last June.
Duchesnay announces the launch of Vablys® (dequalinium chloride vaginal tablets), an antiseptic and anti-infective treatment for bacterial vaginosis
Slynd® (drospirenone), a new progestin-only contraceptive pill from Duchesnay which offers a 24-hour safe window for a missed pill
Duchesnay Pharmaceutical Group donates Quebec-made medicines and vitamins to Ukraine to help those affected by war
Postmenopausal Canadian women experiencing vaginal dryness and painful intercourse have a new oral once-daily prescription treatment, Osphena® (ospemifene tablets) from Duchesnay
